Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis...
The FDA provided clinical guidance on the proposed Alzheimer’s symptom reduction FDA clinical trial and regulatory pathway...
Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows...
CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate...
First-of-its-kind blood volume measurement objectively confirms sample collection quality in every bottle processed, improving confidence in blood culture results...
α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies...
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research...
Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy...
The Spur Stent System was granted FDA De Novo clearance in a high-risk, long-lesion population...
Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors ...
